Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541049
PUBLISHER: IMARC | PRODUCT CODE: 1541049
Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2024-2032
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global blood preparation market size reached US$ 44.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.
Blood Preparation Market Trends:
Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.
Breakup by Product:
Whole Blood
Red Cells
Granulocytes
Plasma
Platelets
Blood Components
Whole Blood Components
Packed Red Cells
Leukocyte Reduced Red Blood Cells
Frozen Plasma
Platelet Concentrate
Cryoprecipitate
Blood Derivatives
Breakup by Antithrombotic and Anticoagulants Type:
Platelet Aggregation Inhibitors
Glycoprotein Inhibitors
COX Inhibitors
ADP Antagonists
Others
Fibrinolytics
Tissue Plasminogen Activator (TPA)
Streptokinase
Urokinase
Anticoagulants
Heparins
Vitamin K Antagonists
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Breakup by Antithrombotic and Anticoagulants Application:
Thrombocytosis
Pulmonary Embolism
Renal Impairment
Angina Blood Vessel Complications
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.
Key Questions Answered in This Report
- 1. What was the size of the global blood preparation market in 2023?
- 2. What is the expected growth rate of the global blood preparation market during 2024-2032?
- 3. What are the key factors driving the global blood preparation market?
- 4. What has been the impact of COVID-19 on the global blood preparation market?
- 5. What is the breakup of the global blood preparation market based on the product?
- 6. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
- 7. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
- 8. What are the key regions in the global blood preparation market?
- 9. Who are the key players/companies in the global blood preparation market?
Product Code: SR112024A4552
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Blood Preparation Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Whole Blood
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Red Cells
- 6.1.2.2 Granulocytes
- 6.1.2.3 Plasma
- 6.1.2.4 Platelets
- 6.1.3 Market Forecast
- 6.2 Blood Components
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Whole Blood Components
- 6.2.2.2 Packed Red Cells
- 6.2.2.3 Leukocyte Reduced Red Blood Cells
- 6.2.2.4 Frozen Plasma
- 6.2.2.5 Platelet Concentrate
- 6.2.2.6 Cryoprecipitate
- 6.2.3 Market Forecast
- 6.3 Blood Derivatives
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Antithrombotic and Anticoagulants Type
- 7.1 Platelet Aggregation Inhibitors
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Glycoprotein Inhibitors
- 7.1.2.2 COX Inhibitors
- 7.1.2.3 ADP Antagonists
- 7.1.2.4 Others
- 7.1.3 Market Forecast
- 7.2 Fibrinolytics
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Tissue Plasminogen Activator (TPA)
- 7.2.2.2 Streptokinase
- 7.2.2.3 Urokinase
- 7.2.3 Market Forecast
- 7.3 Anticoagulants
- 7.3.1 Market Trends
- 7.3.2 Key Segments
- 7.3.2.1 Heparins
- 7.3.2.2 Vitamin K Antagonists
- 7.3.2.3 Direct Thrombin Inhibitors
- 7.3.2.4 Direct Factor Xa Inhibitors
- 7.3.3 Market Forecast
8 Market Breakup by Antithrombotic and Anticoagulants Application
- 8.1 Thrombocytosis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Pulmonary Embolism
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Renal Impairment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Angina Blood Vessel Complications
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Baxter International Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Boehringer Ingelheim International GmbH
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Bristol-Myers Squibb Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Daiichi Sankyo Company Limited
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 GlaxoSmithKline PLC
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Johnson & Johnson Services Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 LEO Pharma A/S
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 SWOT Analysis
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Sanofi S.A.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Baxter International Inc.
Product Code: SR112024A4552
List of Figures
- Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
- Figure 2: Global: Blood Preparation Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2023
- Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2023
- Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2023
- Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2023
- Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: North America: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: United States: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Canada: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: China: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Japan: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: India: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Australia: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Others: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Europe: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Germany: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: France: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Italy: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Spain: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Russia: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Others: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2023
- Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Global: Blood Preparation Industry: SWOT Analysis
- Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
- Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million US$), 2024-2032
- Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million US$), 2024-2032
- Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Blood Preparation Market: Competitive Structure
- Table 7: Global: Blood Preparation Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.